Q8N8S7 (ENAH_HUMAN) Homo sapiens (Human)
Protein enabled homolog UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structure of complex between the 3rd LIM domain of TES and the EVH1 domain of Mena |
Heteromer Q9UGI8; | 3×ZN; | ||||
Assess | ||||||
Complex of the 2nd and 3rd LIM domains of TES with the EVH1 DOMAIN of MENA and the N-Terminal domai… |
Heteromer Q9UGI8; Q9Y615; | 5×ZN; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PPPPTEDEL-NH2 |
Heteromer P33379; | 1×SO4; 2×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-WPPPPTEDEL-NH2 |
Heteromer P33379; | |||||
Assess | ||||||
Structure of human FE65-WW domain in complex with hMena peptide. |
Heteromer O00213; | 1×GOL; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PP-[ProM-1]-OH | homo-2-mer | 3×SO4; 2×GOL; 3×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PP-[ProM-1]-NH2 | homo-2-mer | 1×CL; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-13]-OEt | homo-2-mer | 2×8VK; 7×NO3; 1×SO4; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-17]-OMe | monomer | 1×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-9]-OH | monomer | 3×8TB; 3×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-15]-OH | monomer | 1×K0K; 1×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-1]-NH2 | monomer | 1×NO3; 2×RJQ; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PPPPTEDDL-NH2 | monomer | 1×NO3; 1×SO4; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-4]-OH | monomer | 1×8T5; 2×SO4; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PPPPTEDEA-NH2 | monomer | 3×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PPPP-OH | monomer | 2×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-3]-OH | monomer | 1×8S8; 1×SO4; 1×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-15]-OMe | monomer | 1×K0H; 2×NO3; 1×GOL; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-1]-[ProM-1]-OH | monomer | 1×8SE; 3×SO4; | ||||
Assess | ||||||
EnaH-EVH1 in complex with peptidomimetic low-molecular weight inhibitor Ac-[2-Cl-F]-[ProM-2]-[ProM-… | monomer | 1×3VH; 2×BR; | ||||
Assess | ||||||
ENAH EVH1 domain bound to peptide from ABI1 | monomer | |||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-1]-TEDEL-NH2 | monomer | 6×NO3; 1×GOL; 1×K1N; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-12]-OMe | monomer | 1×8V2; 1×SO4; 1×NO3; 1×GOL; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PP-[ProM-1]-TEDEL-NH2 | monomer | 2×SO4; 2×NO3; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-[ProM-2]-[ProM-12]-OH | monomer | 1×EG5; 2×NO3; 1×SO4; | ||||
Assess | ||||||
ENAH EVH1 in complex with Ac-[2-Cl-F]-PP-[ProM-9]-OH | monomer | 1×BR; | ||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1qc6.1.A | monomer | 0.73 | 72.09 | |||
Assess | ||||||
1use.1.A | monomer | 0.72 | 47.50 | |||
Assess |
4 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 1qc6.1.A | monomer | 0.74 | 72.87 | ||
Assess | ||||||
Isoform 2 | 1use.1.A | monomer | 0.70 | 45.24 | ||
Assess | ||||||
Isoform 3 | 1qc6.1.A | monomer | 0.76 | 72.09 | ||
Assess | ||||||
Isoform 3 | 1use.1.A | monomer | 0.68 | 46.34 | ||
Assess |